China Research and Intelligence (CRI) has emerged to provide high-level research and advisory services to all those with keen interest in different Chinese markets and industries. The firm, founded in 2007, is headquartered in Shanghai, China. Their team’s principle goal is to present the most helpful and reliable insights and information, sincerely serving a broad choice of multinational and local customers with their business practice and ethics.
CRI’s reports are packed with precise analysis of key market indicators, strategic recommendations from industry experts, market estimated figures, projections, reviews of competitive strategies, consumers investigation, reviews of business models, market share analyses, key forces driving of restraining market growth.
CRI’s scope of offerings encircles numerous market research reports, industry analytical reviews, company business reports, industry-specific research databases. Further, the company also offers outsource and custom-tailored services for research organisations, and multiple report readers.
Publications found:
1,334
Sort by:
Investigation Report on China Sertraline Market, 2010-2019
US$ 2,000.00
... China in 1996. Pfizer, Inc., Zhejiang Jingxin Pharmaceutical Co., Ltd, Tianjin Huajin Pharmaceutical Factory, Guangdong P.D. Pharmaceutical Co., Ltd and Chengdu Leer Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Pfizer ...
July 2015
35 pages
Investigation Report on China Paroxetine Market, 2010-2019
US$ 2,000.00
... Ltd, GlaxoSmithKline plc (CA), Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd and Zhejiang Jianfeng Pharmaceutical Holdings occupy the majority of the Chinese market, among which Sino-American Tianjin Smith Kline & French Laboratories Ltd ...
July 2015
35 pages
Investigation Report on China Lentinan Market, 2010-2019
US$ 2,000.00
... JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory, Chuang Li Yao Ye, Kanion Pharmaceutical, Nanjing Luye Sike Pharma Co., Ltd and Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory ...
July 2015
40 pages
Investigation Report on China Adefovir Market, 2010-2019
US$ 2,000.00
... GlaxoSmithKline (Tianjin) Co., Ltd, United Laboratories, Fujian Cosunter Pharmaceutical Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline (Tianjin) Co., Ltd ...
July 2015
35 pages
Investigation Report on China Lamivudine Market, 2010-2019
US$ 2,000.00
... GlaxoSmithKline Pharmaceuticals (Suzhou) Limited, Beijing Wansheng Pharmaceutical Co., Ltd, Burroughs Wellcome & Company (UK) and Fujian Cosunter Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline Pharmaceuticals (Suzhou) Limited ...
July 2015
35 pages
Investigation Report on China Polyene Phosphatidyl Choline Market, 2010-2019
US$ 2,000.00
... Chengdu Tiantaishan Pharmaceutical Co., Ltd, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd and Aventis Pharma S.p.A.(SP) occupy the majority of market share, among which Chengdu Tiantaishan Pharmaceutical Co., Ltd ...
July 2015
30 pages
Investigation Report on China Metformin Market, 2010-2019
US$ 2,000.00
... Sino-American Shanghai Squibb occupy about 80% of the metformin market in China while the rest market share is taken up by such companies as Liling and Hebei Ideal & Hightech Pharmaceutical Co., Ltd. Apart from diabetes, metformin ...
July 2015
30 pages
Investigation Report on China Nateglinide Market, 2010-2019
US$ 2,000.00
... Beijing Novartis Pharma Ltd. took up a market share of about 95% for sales value in 2014 while other companies like Deyuan Pharm, Luoxin Pharmacy Group Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd together occupied about 5% of the nateglinide market in China ...
July 2015
30 pages
Investigation Report on China Glimepiride Market, 2010-2019
US$ 2,000.00
... Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd took up a market share of about 86% for sales value and Sanofi occupied nearly 90% of the glimepiride market in China if Aventis (Italy ...
July 2015
30 pages
Investigation Report on China Gliclazide Market, 2010-2019
US$ 2,000.00
... Servier (France) and its subsidiary Servier (Tianjin) Pharmaceutical Co., Ltd took up a market share of about 96% for sales value in China while other companies like Tianjin Huajin Pharmaceutical Co., Ltd, Helioeast and Beijing Wansheng Pharmaceutical Co., Ltd ...
July 2015
30 pages
Investigation Report on China Olanzapine Market, 2010-2019
US$ 2,000.00
... holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China. As an atypical antipsychotic, olanzapine ... life brought about by China’s economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding ...
June 2015
25 pages
Investigation Report on China Alendronate Sodium Market, 2010-2019
US$ 2,000.00
... Merck Sharp & Dohme (Italy), CSPC Ouyi Pharmaceutical Co., Ltd, Beijing Wansheng Pharmaceutical Co., Ltd, Haini Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd occupy the majority of market share, among which Merck Sharp & Dohme ...
June 2015
30 pages
Investigation Report on China Zoledronic Acid Market, 2010-2019
US$ 2,000.00
... Novartis (Switzerland), Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd occupy the majority of the market share, among which Novartis ...
June 2015
30 pages
Investigation Report on China Thymosin ?1 Market, 2010-2019
US$ 2,000.00
... Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia ...
June 2015
30 pages
Investigation Report on China Sodium Ibandronate Market, 2010-2019
US$ 2,000.00
... China. Currently, sodium ibandronate market in China is mainly occupied by the following companies: Science & Technology General Company Hebei Medical University, Roche Diagnostics GmbH GE), Hencer Pharmacy and Easton Pharmaceutical Co., Ltd, among which Science & Technology General Company Hebei Medical ...
June 2015
30 pages
Investigation Report on China Raloxifene Market, 2010-2019
US$ 2,000.00
... bone mass or osteoporosis while this figure is 30%-50% among women aged 60 and above. Raloxifene (raloxifene hydrochloride), a non-hormone drug against bone resorption, belongs to the second generation of selective estrogen receptor modulator (SERMs ...
June 2015
30 pages
Investigation Report on China Levofloxacin Market, 2010-2019
US$ 2,000.00
... Daiichi Sankyo Co., Ltd (Beijing), Yangtze River Pharmaceutical Group, China Resources Double Crane Pharmaceutical Co., Ltd, Santen Pharmaceutical Co., Ltd (Japan) and Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory have occupied the majority of the market share, among which Daiichi Sankyo ...
June 2015
40 pages
Investigation Report on China Simvastatin Market, 2010-2019
US$ 2,000.00
... Pharmaceutical Co., Ltd, Merck Sharp & Dohme (UK), Guangzhou Nanxin Pharmaceutical Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Shandong Lukang Pharmaceutical Co., Ltd occupy the majority of market, among which Hangzhou MSD Pharmaceutical Co., Ltd ...
June 2015
40 pages
Investigation Report on China Risedronate Sodium Market, 2010-2019
US$ 2,000.00
... Risedronate sodiums in the Chinese market are all produced by local enterprises represented by Kunming Jida Pharmaceutical Co., Ltd, Topfond, Yangtze River Pharmaceutical Group, Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd and Beijing SL Pharm, among which Kunming Jida Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Thrombin Market, 2010-2019
US$ 2,000.00
... thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd ...
June 2015
35 pages
Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019
US$ 2,000.00
... Wyeth Pharmaceutical Co., Ltd (US), Qilu Pharmaceutical Co., Ltd, North China Pharmaceutical Group Corporation, Zhejiang Anglikang Pharmaceutical Co., Ltd and United Laboratories occupy the majority of the Chinese market, among which Wyeth Pharmaceutical Co., Ltd ...
June 2015
35 pages
Investigation Report on China Bromhexine Market, 2010-2019
US$ 2,000.00
... bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Entecavir Market, 2010-2019
US$ 2,000.00
... hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. ... entecavir in China rose from CNY 30 million in 2006 to CNY 1.207 billion in 2014 and CAGR during this period reached up to 55%. Entecavir made by Sino-American Shanghai Squibb Pharmaceuticals Ltd ...
June 2015
30 pages
Investigation Report on China Ganglioside Market, 2010-2019
US$ 2,000.00
... ganglioside sodium in China, among which Qilu Pharmaceutical Co., Ltd, Medical University Pharmaceutical Co., Ltd, Beijing Science Sun Pharmaceutical Co., Ltd, Changchun Xiangtong Pharmaceutical Co., Ltd and Wellso Pharmaceutical take the lion’s share. The marketing of domestic ganglioside ...
June 2015
35 pages
Investigation Report on China Glucosamine Market, 2010-2019
US$ 2,000.00
... Glucosamine is of great demand in China. Most of the market share has been occupied by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd, Bright Future Pharmaceutical Laboratories Limited, Rottapharm Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd ...
June 2015
35 pages
Investigation Report on China Levothyroxine Market, 2010-2019
US$ 2,000.00
... Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones ... Levothyroxine enjoys a vast demand in China. Merck (Germany), Berlin-Chemie AG (Germany) and China Associated Pharmaceutical all take up certain market share, among which Merck ...
June 2015
20 pages
Investigation Report on China Menotropins Market, 2010-2019
US$ 2,000.00
... Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma’anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Moxifloxacin Market, 2010-2019
US$ 2,000.00
... China are mainly produced by Nanjing Youke Pharmaceutical CO., Ltd and The Bayer Group whichowns the larger market share of over 95% for sales value in 2014. As an outstanding antibacterial drug, moxifloxacin ...
June 2015
20 pages
Investigation Report on China Ossotide Market, 2010-2019
US$ 2,000.00
... of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of ... ossotide in China competitive landscape of ossotide in Chinese market price of ossotide made by different enterprises in China market outlook of ossotide in China ...
June 2015
35 pages
Investigation Report on China Progesterone Market, 2010-2019
US$ 2,000.00
... progesterone in the Chinese market is imported and made by Fleet (UK) and Capsugel(FR). The rest mainly comes from such local manufacturers as Asen, Zhejiang Xianju Pharmaceutical Co., Ltd ... steroid drugs will keep growing and that with the development of downstream products, the demand for progesterone ...
June 2015
35 pages
Investigation Report on China Rosuvastatin Market, 2010-2019
US$ 2,000.00
... rosuvastatin (rosuvastatin calcium ... rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals ...
June 2015
35 pages
Investigation Report on China Atorvastatin Market, 2010-2019
US$ 2,000.00
... in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly ... miracle among all the medicines for sale. After entering China, atorvastatin develops fast with annual sales value rising from less ...
June 2015
30 pages
Investigation Report on China Tacrolimus Market, 2010-2019
US$ 2,000.00
... Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus ...
June 2015
30 pages
Investigation Report on China Insulin Lispro Market, 2010-2019
US$ 2,000.00
... : market size of insulin lispro in China market share of manufacturers of Insulin Lispro in China retail price of insulin lispro in Chinese market major manufacturers of insulin lispro in Chinese market market outlook of insulin lispro in China The author suggests ...
June 2015
20 pages
Investigation Report on China Capecitabine Market, 2010-2019
US$ 2,000.00
... name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer ...
June 2015
30 pages
Investigation Report on China Celecoxib Market, 2010-2019
US$ 2,000.00
... the market. In Sep. 2000, celebrex (celecoxib capsule) made by Pfizer Inc was approved by CFDA to enter China. Celecoxib develops fast then, ... celecoxib in Chinese market market outlook of celecoxib in China The author suggests the following groups of people purchase this report: manufacturers of NSAIDs ...
June 2015
20 pages
Investigation Report on China Desloratadine Market, 2010-2019
US$ 2,000.00
... desloratadine in China market share of manufacturers of desloratadine in China price of desloratadine in Chinese market major manufacturers of desloratadine in Chinese market market outlook of desloratadine in China ...
June 2015
30 pages
Investigation Report on China Doxofylline Market, 2010-2019
US$ 2,000.00
... doxofylline in China market share of manufacturers of doxofylline in China price of doxofylline in Chinese market major manufacturers of doxofylline in Chinese market market outlook of doxofylline in China ...
June 2015
30 pages
